Migraine is easy to underestimate because it hides. It rarely lands anyone in a hospital, it is often invisible to everyone but the person having it, and it is frequently dismissed as "just a headache." Yet by the numbers it is one of the most expensive conditions in the United States — and the shape of that cost tells you something important about where it comes from.
The most revealing fact is the last one. The bulk of migraine's economic cost is not people staying home. It is people showing up and working at a fraction of their capacity — present at the desk, unable to think clearly, pushing through. That is why migraine's cost is so easy to miss and so large: it is spread across millions of ordinary days that never look like a health crisis.
The cost also concentrates. In one large study, the 29% of sufferers with the most frequent migraines accounted for roughly half of all the lost productive time. A relatively small group carrying frequent, under-managed migraine drives a disproportionate share of the total — which is the first clue about where a solution would have the most leverage.
Direct medical spending on migraine — office visits, imaging, acute medications like triptans, and the newer preventive drugs — is real but is the smaller share. Emergency-department visits are a tiny fraction. The large majority of the cost is indirect: lost and diminished work, spread invisibly across regular days. This means migraine's cost is not concentrated where the system usually looks (hospitals, procedures) — it is concentrated in daily life.
These are not costs that happen somewhere else, to someone else, absorbed by a system far away. Migraine's cost lands in three places you can recognize.
In your day and your body
If you have migraine, the cost is the obvious part — the pain — and a large hidden part: the days worked at half-capacity, the plans canceled, the anticipatory anxiety of not knowing when the next one lands, the accumulation of small compromises that quietly narrows a life. It is also, often, a cost paid in being disbelieved, because the condition is invisible and intermittent.
In your family and household
Migraine peaks during the years people are raising children and building careers. The cost shows up as the parent who can't make the game, the partner absorbing more than their share on a bad week, the income that plateaus because the condition quietly caps what its bearer can take on. And it shows up on the household ledger — acute medications, visits, and for many, bills that accumulate faster than they resolve.
In your business
If you employ people, migraine is almost certainly one of your largest hidden health costs, and it is nearly all invisible on your claims data — because the expensive part isn't the doctor's visit you're paying for, it's the presenteeism you're not measuring. Roughly 14–19% of a typical workforce has migraine. The cost arrives not as a spike in medical claims but as a persistent, unmeasured drag on output, concentrated in your most experienced people during their most productive years.
At every scale — body, household, business — migraine's cost is diffuse and hidden rather than concentrated and visible. That is exactly why the standard system, organized around visible acute events, handles it so poorly. And it is exactly why a model built around the continuous, everyday relationship has something different to offer.
Here is where most cost discussions stop — with a number too big to do anything about. This framework refuses that ending. The same arc of care that guides an individual patient's recovery can guide the response to a cost like this, and it gives everyone — a person, a family, an employer — a place to start rather than a wall to stare at.
The arc has four movements. We name each in the framework's own terms first, then in the plain terms that make it actionable against a cost.
Keep the cost from causing acute harm right now, before anything else. For an individual, that means using the care already available to you — the preventive visit your plan covers, a real conversation with a clinician instead of another round of over-the-counter masking, and getting ahead of a medical bill before it hardens into debt. The immediate goal is not to cure migraine this week; it is to stop the pattern of under-management that lets a treatable condition run up cost unchecked.
Engage the thing actually generating the cost, rather than the loudest symptom. For migraine, the standard reflex is to treat each attack as it comes. That is relief, and relief matters — but it is not resolution, and a system that only ever relieves will pay for the same migraine again next week. For an employer, this is the stage where the leverage is highest and least used: because a small group of frequent, under-managed sufferers drives so much of the cost, even a modest improvement in how well that group's migraines are managed returns far more than a broad, shallow wellness program. A sample move: rather than a generic wellness perk, make genuine, continuous primary care easy to reach, so the frequent sufferer gets a strategy instead of another emergency refill.
This is the stage the cost conversation almost never reaches, and it is where migraine is unusually responsive. Migraine sits directly on top of the body's foundational regulatory capacities — the stress, diet, and sleep triad. Frequency and severity are strongly shaped by sleep debt, by the physiological load the framework calls stress, and by dietary and hydration patterns. Recovery here is not financial; it is the restoration of the capacity that makes the migraines less frequent in the first place — which is what makes the cost stop regenerating. For an individual, this is learning your own pattern well enough to see a migraine coming and to know which lever moves it. For an employer, it is recognizing that the conditions of work — schedule volatility, sleep-wrecking shift patterns, relentless load — are themselves cost drivers, and that changing them is a health investment, not a soft benefit.
The final movement is structural — the change that keeps a person, or a workforce, out of the cycle rather than cutting the same path again next year. For the individual, this is health agency: understanding your own body and its tendencies well enough to govern the condition yourself, drawing on care precisely when you need it rather than lurching from attack to attack. For the system, it is the model this whole site describes — continuous, arc-oriented primary care delivered through a structure, like the cooperative, that is built to sustain the everyday relationship rather than bill for the occasional crisis. Migraine is a near-perfect illustration of why that structure matters: a diffuse, everyday, foundation-sensitive condition is exactly what continuous care catches and episodic care misses.
None of this claims a cure the rest of medicine lacks. The medications and specialists are real and, for many people, essential. The framework's claim is narrower and more useful: that migraine's cost is driven overwhelmingly by how the condition is delivered against over time — episodically, at the point of pain, with no one holding the arc — and that changing the delivery, not discovering a new drug, is where the cost actually moves. Better delivery is the cause. Lower cost is the effect.